secwatch.observer — SEC 8-K summary
======================================

Issuer:     PHIBRO ANIMAL HEALTH CORP (PAHC)
CIK:        0001069899
Form:       8-K
Filed at:   2024-02-06T23:59:59+00:00
Accession:  0001104659-24-010954
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phibro Animal Health appoints Glenn C. David as CFO effective Feb 9, 2024
-------------------------------------------------------------------------

- Glenn C. David, former Zoetis CFO and group president, joins Phibro as CFO starting Feb 9, 2024.
- David receives $650K base salary, 50% target bonus, $135K signing bonus, and 300K RSUs (half time-vesting, half performance-vesting).
- Performance RSUs vest based on 90-day average stock price from $20 to $60+ over 5 years.
- Interim CFO Richard Johnson will stay in advisory role for smooth transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069899/000110465924010954/0001104659-24-010954-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069899/000110465924010954/tm245238d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-010954

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer